Among them, mutation or methylation of the VHL gene (seen in 90% of sporadic ccRCC) promotes tumor progression through aberrant accumulation of hypoxia-inducible factor (HIF), which activates angiogenic and glycolytic pathways (Kumar et al., 2018; Bahadoram et al., 2022). Here, VHL is linked to nonpapillary renal cell carcinoma.